Progyny (PGNY) Tops Q3 EPS by 1c, Revenues Beat; Offers Q4 & FY19 EPS/Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Progyny, Inc. Announces Third Quarter 2019 Results
December 4, 2019 4:04 PM ESTReports 120% Increase in Third Quarter Revenue to $61.2 MillionIssues Revenue Guidance of $65.0 to $66.5 Million for the Fourth Quarter of 20192019 Selling Season Concludes with Commitments from Record Number of New Clients
NEW YORK, Dec. 04, 2019 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its financial results for the three month period ended September 30, 2019 (the third quarter of 2019 or the current period) as compared to the three month period ended September 30, 2018 (the third quarter of 2018 or the prior... More
